Clue, a Berlin-based women’s health app, has raised $13 million in a recent funding round. The app, which helps women track their menstrual cycle and fertility, has become increasingly popular in recent years as women look for new ways to take control of their health and well-being.
The funding round was led by Union Square Ventures, with participation from Mosaic Ventures, Brigitte Mohn and Tom Stafford, and other notable investors. The new funding will be used to expand the app’s features and capabilities, as well as to support the company’s continued growth and expansion.
Clue was founded in 2013 by Ida Tin, who saw a need for a better way for women to track their menstrual cycle and fertility. The app uses data analytics and machine learning to provide personalized insights and recommendations based on a woman’s individual cycle and health history.
Since its launch, Clue has become one of the most popular women’s health apps in the world, with over 12 million users in more than 190 countries. The app has been praised for its user-friendly interface, accurate tracking, and helpful insights and recommendations.
The new funding will allow Clue to expand its offerings beyond just menstrual and fertility tracking. The company is exploring new features and capabilities, such as pregnancy tracking, menopause support, and general health and wellness advice. The goal is to create a comprehensive women’s health platform that provides a range of tools and resources to help women take control of their health and well-being.
Clue is also looking to expand its global reach, particularly in emerging markets where there is a growing need for women’s health resources. The company has already translated the app into 15 languages and is exploring partnerships with local health organizations and providers.
In addition to its app, Clue is also focused on advancing women’s health research. The company has a team of researchers and scientists who are working to better understand women’s health and well-being, with a particular focus on menstrual and reproductive health.
The new funding will help support Clue’s research efforts, as well as its collaborations with other researchers and institutions. The goal is to help advance the field of women’s health and improve outcomes for women around the world.
In conclusion, Clue’s recent $13 million funding round is a significant achievement for the company and a testament to the growing demand for women’s health resources. With its user-friendly app, personalized insights, and commitment to advancing women’s health research, Clue is well-positioned to continue growing and expanding its reach. As the company continues to innovate and develop new features and capabilities, it has the potential to become a leading provider of women’s health resources around the world.
